company

MIM PHARMA AS

0349 OSLO

Return on Equity
79,41 %
Current Ratio
0,44
Debt-to-Equity Ratio
−1,79
Key figures (NOK)2022
Revenue0
Net Income−81 000
Total Assets97 000
Total Equity−102 000
Income (NOK)2022
Revenue0
Expenditure81 000
Operating Profit−81 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax−81 000
Tax0
Net Income−81 000
Balance (NOK)2022
Total Fixed Assets90 000
Total Current Assets7 000
Total Assets97 000
Total Retained Equity−1 563 000
Total Equity−102 000
Total Long-Term Debt183 000
Total Current Debt16 000
Total Equity and Debt97 000
Cash flow (NOK)2022
Sales Income0
Other Income0
Revenue0
Cost of Goods Sold0
Salary Costs0
Depreciation41 000
Impairment0
Expenditure81 000
Operating Profit−81 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income−81 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets90 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets90 000
Stock0
Total Investments0
Cash, Bank7 000
Total Current Assets7 000
Total Assets97 000
Total Equity−102 000
Short-Term Group Debt0
Total Long-Term Debt183 000
Creditors9 000
Unpaid Taxes3 000
Dividends0
Other Current Debt4 000
Total Current Debt16 000
Total Equity and Debt97 000
Financial indicators2022
Return on Equity79,41 %
Debt-to-Equity Ratio−1,79
Operating Profit Margin-
Current Ratio0,44
Quick Ratio0,44
Equity Ratio−1,05
Gross Profit Margin-
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English